Abstract
The previous finding that electroconvulsive therapy (ECT) enhances effects of dopamine (DA) agonists was further investigated in the present clinical experiment using neuroendocrine techniques. Apomorphine chloride (AP) (0.18–0.24 mg IV) induced stimulation of growth hormone (GH) and suppression of prolactin (PRL), as shown 2–3 days before and after ECT in mentally depressed patients (N=12) and therapy-resistant parkinsonian patients with on-off phenomena (N=9). AP-stimulated GH secretion was not significantly affected by ECT, whereas AP-induced suppression of PRL, expressed as percentage of baseline PRL levels, was significantly enhanced after ECT. Changes in clinical and hormonal parameters were not significantly correlated. Control patients not receiving ECT showed no significant changes in AP-induced GH secretion or PRL suppression in repeated investigations. The results support the view that ECT increases responsiveness of DA receptors and indicates that AP-induced suppression of PRL is a useful model to reflect these changes in humans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åsberg M, Kragh-Sørensen P, Mindham RHS, Tuck JR (1973) International reliability and communicability of a rating scale for depression. Psychol Med 3:458–465
Balldin J, Bolle P, Edén S, Eriksson E, Modigh K (1980a) Effects of electroconvulsive treatment on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats. Psychoneuroendocrinology 5:329–337
Balldin J, Edén S, Granérus AK, Modigh K, Svanborg A, Wålinder J, Wallin L (1980b) Electroconvulsive therapy in Parkinson's syndrome with on-off phenomenon. J Neural Transm 47:11–21
Balldin J, Granérus AK, Lindstedt G, Modigh K, Wålinder J (1981) Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms. J Neural Transm 52: 199–211
Bergstrom DA, Kellar KJ (1979) Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature 278:464–466
Brambilla F, Bellodi L, Negri F, Smeraldi E, Malagoli G (1979) Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli. Psychoneuroendocrinology 4:329–339
Brown WA, van Woert MH, Ambani LM (1973) Effect of apomorphine on growth hormone release in humans. J Clin Endocrinol Metab 37:463–465
Camanni F, Massara F, Belforte L, Molinatti GM (1975) Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-α-ergocryptine. J Clin Endocrinol Metab 40:363–366
Checkley SA (1980) Neuroendocrine tests of monamine function in man: A review of basic theory and its application to the study of depressive illness. Psychol Med 10:35–53
Chiodini PG, Liuzzi A, Botalla L, Cremascoli G, Silvestrini F (1974) Inhibitory effect of dopaminergic stimulation on GH release in acromegaly. J Clin Endocrinol Metab 38:200–206
Cromholm B, Ottosson JO (1960) Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression: The role of electric stimulation and of the seizure studied by variation of stimulus and modification by lidocaine of seizure discharge. Acta Psychiatr Neurol Scand (Suppl) 145, 69–97
Denef C, Manet D, Dewals R (1980) Dopaminergic stimulation of prolactin release. Nature 285:243–246
Edén S, Modigh K (1977) Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res 129:379–384
Green AR, Heal DJ, Grahame-Smith DG (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52:195–200
Heal DJ, Green AR (1978) Repeated electroconvulsive shock increases the behavioural responses to injection of both dopamine and dibutyryl-cyclic-AMP into nucleus accumbens. Neuropharmacology 17:1085–1087
Lal S, Nair NPV (1979) Growth hormone and prolactin responses in neuropsychiatric research. In: Müller EE, Agnoli A (eds) Neuroendocrine correlates in neurology and psychiatry. Elsevier-North Holland Biomedical Press, Amsterdam, pp 179–194
Lal S, de la Vega CE, Sourkes TL, Friesen HG (1972) Effect of apomorphine on human growth hormone secretion. Lancet II, 661
Lal S, de la Vega CE, Sourkes TL, Friesen HG (1973) Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle stimulating hormone levels in human serum. J Clin Endocrinol Metab 37:719–724
Malcolm ADB (1981) Production and processing of prolactin. Nature 290
Modigh K (1975) Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine-pretreated mice by repeated ECS. J Neural Transm 36:19–32
Modigh K, Jackson DM (1975) Evidence for sustained effect of ECS on neuronal structures connected to brain catecholamines neurons. Finn Pharmacol Soc Abstract 394
Praag van HM (1980) Central monoamine metabolism in depressions. II. Catecholamines and related compounds. Compr Psychiatry 21:44–54
Praag van HM, Korf J (1975) Central monoamine deficiency in depressions: Causative or secondary phenomenon? Pharmakopsychiatrie 8:322–326
Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309–314
Tamminga CA, Smith RC, Pandey G, Frohman LA, Davis JM (1977) A neuroendocrine study of supersensitivity in tardive dyskinesia. Arch Gen Psychiatry 34:1199–1203
Thorell JI, Johansson BG (1971) Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta 251:363–369
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balldin, J., Granérus, A.K., Lindstedt, G. et al. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacology 76, 371–376 (1982). https://doi.org/10.1007/BF00449127
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00449127